Enhanced graphite phase carbon nitride composite bone scaffold material and preparation method thereof

By using the bone stent combined with the PLLA matrix after bone tumor resection, the anti-tumor problem after bone tumor resection is solved, the anti-tumor performance and mechanical strength are improved, and the new bone formation of bone defects is promoted. Provides a new theoretical basis for treatment.

CN118873751APending Publication Date: 2024-11-01CENT SOUTH UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410961716.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-18
Publication Date
2024-11-01

AI Technical Summary

Technical Problem

The prior art is difficult to effectively match the three-dimensional stereoscopic bone defect morphology after bone tumor resection and long-term anti-tumor, and the wide band gap of graphite phase carbon nitride photocatalyst leads to poor anti-tumor performance.

Method used

Graphite phase carbon nitride nanosheets were synthesized by calcination to form Ce6@pCN composite material, combined with levo polylactic acid (PLLA) matrix, and personalized porous bone scaffolds were prepared using selective laser sintering technology to gradually release Ce6@pCN to induce tumor cells Apoptosis.

Benefits of technology

It improves the light absorption performance and ROS yield of Ce6, enhances anti-tumor performance, promotes bone tumor treatment, and improves the mechanical strength and biocompatibility of bone stents, solving the problems of bone tumor recurrence and bone defects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118873751A_ABST
    Figure CN118873751A_ABST
Patent Text Reader

Abstract

The invention provides an enhanced graphite phase carbon nitride composite bone scaffold material and a preparation method thereof. The composite bone scaffold material is prepared from poly-L-lactic acid and Ce6 atpCN composite powder. The prepared composite bone scaffold is good in anti-tumor performance, high in biological activity and high in plasticity, the problem of tumor recurrence caused by residual tumor cells after bone tumor resection can be solved, and bone defects can be filled to induce new bone formation. The invention provides a new theoretical basis for treating oral and maxillofacial bone tumors.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of 3D printed bone scaffolds, and in particular to an enhanced graphite phase carbon nitride composite bone scaffold material with photodynamic effect and a preparation method thereof. Background Art

[0002] The residual tumor cells in three-dimensional bone defects are the key to recurrence after bone tumor resection. Once the residual tumor cells proliferate rapidly and cause tumor recurrence, it not only increases the difficulty of secondary surgery, but the complex tumor and subsequent treatment also cause secondary damage to the bone tissue that has not fully recovered in the affected area. At present, anti-tumor drugs are often used in clinical practice after tumor resection, but these drugs have the disadvantages of low local effective concentration, inability to match the morphology of three-dimensional bone defects and long-term anti-tumor effects. Polylactic acid (PLLA) is one of the biomedical materials approved by the US Food and Drug Administration, with good biocompatibility, easy processing and degradability. Through selective laser sintering technology (SLS), PLLA can be prepared into personalized bone scaffolds with mechanical properties comparable to human bone tissue and porous structures suitable for tissue cell growth, which lays the foundation for the long-term anti-tumor effect of bone scaffolds in bone defect areas.

[0003] Graphitic carbon nitride (g-C3N4), a non-metallic photocatalyst, has the advantages of good structural stability and biocompatibility, and a band gap suitable for generating reactive oxygen species (ROS). Under visible light, g-C3N4 generates photogenerated carriers, which then transfer the charges to the surrounding H2O and O2, promoting the generation of ·OH, 1 The generation of ROS such as O2 induces excessive ROS in tumor cells. These ROS can interfere with mitochondrial genes, oxidatively damage lipids and proteins, reduce mitochondrial biosynthesis, and reduce ATP production. They can also affect the mitochondrial membrane pores, causing changes in ion flow, thereby reducing mitochondrial membrane potential, and even causing mitochondrial swelling and rupture, ultimately inducing tumor cell apoptosis. However, due to the wide band gap, g-C3N4 has a serious problem of carrier recombination, which limits its efficiency in generating ROS and leads to poor anti-tumor performance.

[0004] Chlorin e6 (Ce6) is a photosensitizer that has been certified by the US FDA as having high biosafety and photosensitivity. It has a narrow band gap structure and is commonly used in anti-tumor treatment. The g-C3N4 nanosheets with a large specific surface area can effectively adsorb Ce6 after surface protonation (pCN) to form a Ce6@pCN heterojunction structure. On the one hand, after forming a heterojunction, the light absorption range of the Ce6@pCN composite material is red-shifted, and the light absorption performance is improved; on the other hand, under the action of visible light, the heterojunction structure accelerates the separation and transfer of electrons and holes, and the ROS yield is increased. Therefore, Ce6 was synthesized on pCN nanosheets, and then introduced into the PLLA matrix, and a personalized porous PLLA / Ce6@pCN composite bone scaffold was prepared by SLS technology. The tailored bone scaffold gradually releases Ce6@pCN in all directions while degrading, achieving the purpose of gradually degrading and disappearing while comprehensively inducing tumor cell apoptosis.

[0005] The study found that domestic and foreign research mainly focused on improving the catalytic performance of Ce6@pCN composite materials, and no research was found on introducing the dual photodynamic anti-tumor system into bone scaffolds to promote bone tumor treatment. Summary of the invention

[0006] In order to fill the gap in the prior art of introducing the dual photodynamic anti-tumor system into bone scaffolds to promote bone tumor treatment, the present application proposes a method for preparing an enhanced graphite phase carbon nitride composite bone scaffold material.

[0007] The technical solution adopted by the present invention is:

[0008] A method for preparing an enhanced graphite phase carbon nitride composite bone scaffold material, the preparation steps are as follows:

[0009] (1) synthesizing bCN powder by calcination method, and then synthesizing pCN powder by one-step ion exchange method;

[0010] (2) Growing Ce6 on pCN nanosheets by magnetic stirring to obtain Ce6@pCN composite powder;

[0011] (3) PLLA powder was mixed with Ce6@pCN composite powder and subjected to dispersion, centrifugation, vacuum drying and other steps to obtain PLLA / Ce6@pCN powder, which was then printed and prepared using selective laser sintering technology to prepare PLLA / Ce6@pCN composite bone scaffold.

[0012] The present invention provides a method for preparing a composite material. The preparation steps of the Ce6@pCN composite powder are as follows: taking melamine powder through a calcination method to obtain bCN powder; dispersing bCN in a hydrochloric acid solution, and obtaining pCN powder after centrifugal drying; dispersing pCN and Ce6 together in deionized water to prepare a Ce6@pCN composite solution; the composite solution is first repeatedly washed and centrifuged with deionized water and ethanol, and then dried in a vacuum drying oven to obtain Ce6@pCN powder.

[0013] The present invention proposes an implementation mode, in which the PLLA / Ce6@pCN composite powder comprises the following components in parts by weight: 92-98 parts of PLLA powder and 2-8 parts of Ce6@pCN composite powder.

[0014] The present invention proposes an implementation mode, in which Ce6@pCN composite powder comprises the following components by weight: 8-12 parts of Ce6 powder and 88-92 parts of pCN powder.

[0015] The present invention provides a method for preparing a composite bone scaffold material. The preparation method of the PLLA / Ce6@pCN composite powder is as follows: taking any one of the composite bone scaffold material components, PLLA and Ce6@pCN, dispersing them in anhydrous ethanol to obtain a suspension, and then drying and grinding to obtain the PLLA / Ce6@pCN powder.

[0016] The present invention proposes an implementation mode, wherein the diameter of the bCN and pCN nanosheets is 1-5 um and the thickness is 0.5-3 nm.

[0017] The present invention proposes an implementation mode, wherein the dispersion method is ultrasound and / or magnetic stirring, the ultrasonic dispersion time is 10-30 minutes, and the temperature is 10-40°C; the magnetic stirring dispersion time is 10-300 minutes, and the temperature is 20-30°C; the centrifugal time is 3-10 minutes, and the centrifugal speed is 10000-15000r / min.

[0018] The present invention proposes an implementation method, wherein the vacuum drying temperature is set to 50-80° C., the drying time is 10-24 hours, and the grinding time of the powder obtained by drying is 10-60 minutes.

[0019] The present invention provides a method for preparing a composite bone scaffold, wherein the prepared PLLA / Ce6@pCN powder is placed in a laser sintering 3D printing system for personalized printing according to 3D modeling. The steps for preparing the composite bone scaffold are: preheating the powder, spreading the powder on the printing interface, layered scanning to solidify the powder material, spreading the next layer of powder, sintering, and forming, and removing excess unsintered powder after repeated multiple times to obtain a composite bone scaffold.

[0020] The present invention proposes an implementation method, wherein the process parameters of selective laser sintering are: laser power of 0.5-2W, scanning speed of 100-200m / s, layer thickness of 0.1-0.2mm, and powder bed preheating temperature of 140-160°C.

[0021] The beneficial effects of the present invention are:

[0022] In the present invention, Ce6 and g-C3N4 react in aqueous solution to form a heterojunction structure, and Ce6 grows in situ on the surface of g-C3N4, which not only improves the stability of Ce6, but also promotes the charge transfer between composite materials. The present invention utilizes Ce6 to enhance the electron-hole separation efficiency of g-C3N4, improves the photocatalytic ability of g-C3N4, and at the same time, g-C3N4 also improves the photodynamic effect of Ce6, thereby promoting the ROS generation of PLLA / Ce6@pCN bone scaffolds, which is beneficial to anti-bone tumor treatment. Among them, Ce6@pCN is introduced into the PLLA matrix to prepare a bone scaffold, which improves the hydrophilicity and mechanical strength of the PLLA-based scaffold, and is beneficial to adapt to the biological environment of bone defects. The composite bone scaffold finally formed has good anti-tumor performance, high biological activity, and strong plasticity. It can not only solve the problem of tumor recurrence caused by residual tumor cells after bone tumor resection, but also fill bone defects to induce new bone formation. Provide a new theoretical basis for the treatment of oral and maxillofacial bone tumors. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 Transmission electron microscopy images of Ce6@pCN composite powder in Example 1, (a) transmission electron microscopy image of Ce6@pCN composite powder, (b) is a local enlarged image of (a), (c) diffraction pattern of pCN, (d) element distribution map of Ce6@pCN, indicating the successful synthesis of Ce6@pCN;

[0024] Figure 2 The photoluminescence spectra of bCN, pCN and Ce6@pCN in Example 1 indicate that the incorporation of Ce6 can effectively prevent the recombination of electron-hole pairs of pCN, thereby obtaining a stronger photodynamic effect;

[0025] Figure 3 The transient photocurrent spectra of bCN and Ce6@pCN in Example 1 show that the photogenerated electrons and holes of Ce6@pCN recombine less after separation;

[0026] Figure 4 The electrochemical impedance diagrams of bCN and Ce6@pCN in Example 1 show that Ce6@pCN has lower resistance and better electron transport, thus achieving a higher photocatalytic rate;

[0027] Figure 5These are the cytotoxicity test diagrams of the PLLA / Ce6@pCN bone scaffold prepared in Example 1 and other bone scaffolds prepared in Comparative Examples 1-3, indicating that the PLLA / Ce6@pCN bone scaffold can effectively kill bone tumor cells under light. DETAILED DESCRIPTION

[0028] The specific implementation method of the present invention is further described below in conjunction with specific embodiments, but the described embodiments are only part of the embodiments of the present invention, and the content of the present invention is not limited thereto. Unless otherwise defined, the technical terms used in the following embodiments have the same meanings as those generally understood by technicians in the field to which the present invention belongs. The test reagents used in the following embodiments, unless otherwise specified, are all conventional biochemical reagents; the experimental methods, unless otherwise specified, are all conventional methods.

[0029] Example 1

[0030] (1) After grinding 12g of melamine powder for 30min, it was placed in a ceramic crucible with a lid and heated to 550℃ in a muffle furnace at a rate of 5℃ / min for 2h; after cooling, it was ground to obtain bCN powder. The prepared 1g bCN was rapidly magnetically stirred in 200mL of hydrochloric acid solution (1M) at 25℃ for 5h; the solution was repeatedly washed with deionized water and ethanol for 3 times, each centrifugation time was 3min, and the centrifugal speed was 12000r / min; the powder after centrifugation was dried in a vacuum drying oven at 80℃ for 12h and ground to obtain pCN powder. 0.5g pCN, 0.05g Ce6 and 100mL deionized water were placed in a beaker and magnetically stirred at 25℃ for 2h; according to the preparation conditions of pCN, centrifugation, washing and drying were performed to obtain Ce6@pCN composite powder.

[0031] (2) 4.75 g of PLLA powder was placed in a container containing 100 ml of anhydrous ethanol and subjected to ultrasonic treatment for 30 min at 25°C to form a PLLA suspension; 0.25 g of Ce6@pCN powder was then added to the PLLA suspension and subjected to ultrasonic treatment for 30 min, magnetically stirred for 2 h at 25°C to obtain a PLLA / Ce6@pCN suspension; the mixture was then repeatedly centrifuged for 10 min at a speed of 12,000 r / min; and finally, the mixture was dried in a vacuum drying oven at 80°C for 12 h and ground for 10 min to obtain a PLLA / Ce6@pCN composite powder.

[0032] (3) The prepared PLLA / Ce6@pCN powder is placed in a laser sintering 3D printing system for personalized printing according to 3D modeling. The steps for preparing the composite bone scaffold are as follows: the prepared PLLA / Ce6@pCN powder is placed in the powder bed of the laser sintering system for preheating; the mixed powder is selectively layered and scanned and quickly solidified with the printing parameters of laser power of 2W, scanning speed of 120mm / min, layer thickness of 0.1mm, and powder bed preheating temperature of 150℃; after one layer is sintered, the next layer of powder is spread, sintered, and formed, and the next layer is sintered together with the previous layer, and this cycle is repeated until the scaffold is sintered.

[0033] In this embodiment, the composite bone scaffold printed with PLLA / Ce6@pCN composite powder was observed, and the results showed that there were no obvious defects and the shape accuracy was high.

[0034] In this embodiment, the mechanical property test found that the ultimate compressive strength of the PLLA / Ce6@pCN composite bone scaffold was 35 MPa, which is similar to the mechanical strength of the regenerated tissue.

[0035] In this embodiment, the in vitro anti-tumor test found that after illumination (1 h / day, 2 days), the PLLA / Ce6@pCN composite bone scaffold promoted apoptosis of most tumor cells.

[0036] In this embodiment, the biocompatibility test found that under dark conditions, the PLLA / Ce6@pCN composite bone scaffold had no obvious toxicity to cells, showing good biocompatibility.

[0037] Example 2

[0038] (1) 5 g of melamine powder was ground for 10 min and then placed in a ceramic crucible with a lid. The mixture was heated to 550 °C in a muffle furnace at a rate of 5 °C / min for 2 h. After cooling, the mixture was ground to obtain bCN powder. 1 g of the prepared bCN was rapidly magnetically stirred in 200 mL of hydrochloric acid solution (1 M) at 22 °C for 5 h. The solution was repeatedly washed with deionized water and ethanol for 3 times, each time with a centrifugal time of 5 min and a centrifugal speed of 10,000 r / min. The powder after centrifugation was dried in a vacuum drying oven at 80 °C for 12 h and ground to obtain pCN powder. 0.46 g of pCN, 0.04 g of Ce6 and 100 mL of deionized water were placed in a beaker and magnetically stirred at 22 °C for 2 h. According to the preparation conditions of pCN, the mixture was centrifuged, washed and dried to obtain Ce6@pCN composite powder.

[0039] (2) 4.85 g of PLLA powder was placed in a container containing 100 ml of anhydrous ethanol and subjected to ultrasonic treatment for 20 min at 22°C to form a PLLA suspension. Then, 0.15 g of Ce6@pCN powder was added to the PLLA suspension and subjected to ultrasonic treatment for 20 min. The mixture was magnetically stirred for 3 h at 22°C to obtain a PLLA / Ce6@pCN suspension. The mixture was then repeatedly centrifuged for 5 min at a speed of 10,000 r / min. Finally, the mixture was dried in a vacuum drying oven at 80°C for 12 h and ground for 10 min to obtain a PLLA / Ce6@pCN composite powder.

[0040] (3) The prepared PLLA / Ce6@pCN powder is placed in a laser sintering 3D printing system for personalized printing according to 3D modeling. The steps for preparing the composite bone scaffold are as follows: the prepared PLLA / Ce6@pCN powder is placed in the powder bed of the laser sintering system for preheating; the mixed powder is selectively layered and scanned and quickly solidified with the printing parameters of laser power of 1.5W, scanning speed of 150mm / min, layer thickness of 0.2mm, and powder bed preheating temperature of 140℃; after one layer is sintered, the next layer of powder is spread, sintered, and formed, and the next layer is sintered together with the previous layer, and this cycle is repeated until the scaffold is sintered.

[0041] In this embodiment, the composite bone scaffold printed with PLLA / Ce6@pCN composite powder was observed, and the results showed that there were no obvious defects and the shape accuracy was high.

[0042] In this embodiment, the mechanical property test found that the ultimate compressive strength of the PLLA / Ce6@pCN composite bone scaffold was 25 MPa, which is similar to the mechanical strength of the regenerated tissue.

[0043] In this embodiment, the in vitro anti-tumor test found that after illumination (1 h / day, 2 days), the PLLA / Ce6@pCN composite bone scaffold promoted apoptosis of most tumor cells.

[0044] In this embodiment, the biocompatibility test found that under dark conditions, the PLLA / Ce6@pCN composite bone scaffold had no obvious toxicity to cells, showing good biocompatibility.

[0045] Example 3

[0046] (1) After grinding 10g of melamine powder for 60min, it was placed in a ceramic crucible with a lid and heated to 550℃ in a muffle furnace at a rate of 5℃ / min for 2h; after cooling, it was ground to obtain bCN powder. The prepared 1g of bCN was rapidly magnetically stirred in 200mL of hydrochloric acid solution (1M) at 27℃ for 5h; the solution was repeatedly washed with deionized water and ethanol for 3 times, each centrifugation time was 2min, and the centrifugal speed was 15000r / min; the powder after centrifugation was dried in a vacuum drying oven at 80℃ for 12h and ground to obtain pCN powder. 0.44g of pCN, 0.06g of Ce6 and 100mL of deionized water were placed in a beaker and magnetically stirred at 27℃ for 2h; according to the preparation conditions of pCN, centrifugation, washing and drying were carried out to obtain Ce6@pCN composite powder.

[0047] (2) 4.65 g of PLLA powder was placed in a container containing 100 ml of anhydrous ethanol and subjected to ultrasonic treatment for 30 min at 27°C to form a PLLA suspension; 0.35 g of Ce6@pCN powder was then added to the PLLA suspension and subjected to ultrasonic treatment for 30 min. The mixture was magnetically stirred for 2 h at 27°C to obtain a PLLA / Ce6@pCN suspension; the mixture was centrifuged repeatedly for 2 min at a speed of 15,000 r / min; the mixture was dried in a vacuum drying oven at 80°C for 12 h and ground for 60 min to obtain a PLLA / Ce6@pCN composite powder.

[0048] (3) The prepared PLLA / Ce6@pCN powder is placed in a laser sintering 3D printing system for personalized printing according to 3D modeling. The steps for preparing the composite bone scaffold are as follows: the prepared PLLA / Ce6@pCN powder is placed in the powder bed of the laser sintering system for preheating; the mixed powder is selectively layered and scanned and quickly solidified with the printing parameters of laser power of 1.0W, scanning speed of 100mm / min, layer thickness of 0.1mm, and powder bed preheating temperature of 160℃; after one layer is sintered, the next layer of powder is spread, sintered, and formed, and the next layer is sintered together with the previous layer, and this cycle is repeated until the scaffold is sintered.

[0049] In this embodiment, the composite bone scaffold printed with PLLA / Ce6@pCN composite powder was observed, and the results showed that there were no obvious defects and the shape accuracy was high.

[0050] In this embodiment, the mechanical property test found that the ultimate compressive strength of the PLLA / Ce6@pCN composite bone scaffold was 32 MPa, which is similar to the mechanical strength of the regenerated tissue.

[0051] In this embodiment, the in vitro anti-tumor test found that after illumination (1 h / day, 2 days), the PLLA / Ce6@pCN composite bone scaffold promoted apoptosis of most tumor cells.

[0052] In this embodiment, the biocompatibility test found that under dark conditions, the PLLA / Ce6@pCN composite bone scaffold had no obvious toxicity to cells, showing good biocompatibility.

[0053] Comparative Example 1

[0054] (1) 5g of PLLA powder was placed in a laser sintering 3D printing system for personalized printing according to 3D modeling. The steps for preparing PLLA bone scaffolds are as follows: PLLA powder was placed in the powder bed of the laser sintering system for preheating; the PLLA powder was selectively layered and scanned and quickly solidified with the printing parameters of laser power of 2.0W, scanning speed of 120mm / min, layer thickness of 0.1mm, and powder bed preheating temperature of 150℃; after one layer of sintering was completed, the next layer of powder was spread, sintered, and formed, and the next layer was sintered together with the previous layer, and this cycle was repeated until the scaffold was sintered.

[0055] In this embodiment, bone scaffolds printed with PLLA powder were observed, and the results showed no obvious defects and high shape accuracy.

[0056] In this embodiment, the mechanical property test found that the ultimate compressive strength of the PLLA bone scaffold was 21 MPa.

[0057] In this embodiment, the in vitro anti-tumor test found that after irradiation (1 h / day, 2 days), the PLLA bone scaffold only caused a small amount or almost no apoptosis of tumor cells.

[0058] In this embodiment, the biocompatibility test found that under dark conditions, the PLLA bone scaffold had no obvious toxicity to cells, showing good biocompatibility.

[0059] Comparative Example 2

[0060] (1) 5 g of melamine powder was ground for 30 min and then placed in a ceramic crucible with a lid. The crucible was heated to 550 °C in a muffle furnace at a rate of 5 °C / min for 2 h. After cooling, the crucible was ground for 30 min to obtain bCN powder.

[0061] (2) 4.75 g of PLLA powder was placed in a container containing 100 ml of anhydrous ethanol, and ultrasonically treated for 30 min at a temperature of 25°C to form a PLLA suspension; then 0.25 g of bCN powder was added to the PLLA suspension, and ultrasonically treated for 30 min, magnetically stirred for 2 h at a temperature of 25°C to obtain a PLLA / bCN suspension; the mixture was repeatedly centrifuged for 3 min at a speed of 12,000 r / min; finally, the mixture was dried in a vacuum drying oven at 80°C for 12 h, and ground for 30 min to obtain a PLLA / bCN composite powder.

[0062] (3) The prepared PLLA / bCN powder is placed in a laser sintering 3D printing system for personalized printing according to 3D modeling. The steps for preparing the PLLA / bCN bone scaffold are as follows: the PLLA / bCN powder is placed in the powder bed of the laser sintering system for preheating; the PLLA / bCN powder is selectively layered and scanned and quickly solidified with the printing parameters of laser power of 2.0W, scanning speed of 120mm / min, layer thickness of 0.1mm, and powder bed preheating temperature of 150℃; after one layer is sintered, the next layer of powder is spread, sintered, and formed, and the next layer is sintered together with the previous layer, and this cycle is repeated until the scaffold is sintered.

[0063] In this embodiment, the composite bone scaffold printed with PLLA / bCN powder was observed, and the results showed no obvious defects and high shape accuracy.

[0064] In this embodiment, the mechanical property test found that the ultimate compressive strength of the PLLA bone scaffold was 29 MPa.

[0065] In this embodiment, the in vitro anti-tumor test found that after irradiation (1 h / day, 2 days), the PLLA / bCN bone scaffold caused apoptosis of some tumor cells.

[0066] In this embodiment, the biocompatibility test found that under dark conditions, the PLLA bone scaffold had no obvious toxicity to cells, showing good biocompatibility.

[0067] Comparative Example 3

[0068] (1) 8 g of melamine powder was ground for 30 min and then placed in a ceramic crucible with a lid, and heated to 550°C in a muffle furnace at a rate of 5°C / min for 2 h; after cooling, the powder was ground to obtain bCN powder. 3 g of the prepared bCN was rapidly magnetically stirred in 200 mL of hydrochloric acid solution (1 M) at 25°C for 5 h; the solution was repeatedly washed with deionized water and ethanol for 3 times, each time with a centrifugal time of 3 min and a centrifugal speed of 12000 r / min; the powder after centrifugation was dried in a vacuum drying oven at 80°C for 12 h and ground to obtain pCN powder.

[0069] (2) 4.75 g of PLLA powder was placed in a container containing 100 ml of anhydrous ethanol and subjected to ultrasonic treatment for 30 min at 25°C to form a PLLA suspension; 0.25 g of pCN powder was then added to the PLLA suspension and subjected to ultrasonic treatment for 30 min, magnetically stirred for 2 h at 25°C to obtain a PLLA / pCN suspension; the suspension was then repeatedly centrifuged for 3 min at a speed of 12,000 r / min; and finally, the suspension was dried in a vacuum drying oven at 80°C for 12 h and ground for 30 min to obtain a PLLA / pCN composite powder.

[0070] (3) The prepared PLLA / pCN powder is placed in a laser sintering 3D printing system for personalized printing according to 3D modeling. The steps for preparing the PLLA / pCN bone scaffold are as follows: the PLLA powder is placed in the powder bed of the laser sintering system for preheating; the PLLA / pCN powder is selectively layered and scanned and quickly solidified with the printing parameters of laser power of 2.0W, scanning speed of 120mm / min, layer thickness of 0.1mm, and powder bed preheating temperature of 150℃; after one layer is sintered, the next layer of powder is spread, sintered, and formed, and the next layer is sintered together with the previous layer, and this cycle is repeated until the scaffold is sintered.

[0071] In this embodiment, the composite bone scaffold printed with PLLA / pCN powder was observed, and the results showed that there were no obvious defects and the shape accuracy was high.

[0072] In this embodiment, the mechanical property test found that the ultimate compressive strength of the PLLA bone scaffold was 32 MPa.

[0073] In this embodiment, the in vitro anti-tumor test found that after irradiation (1 h / day, 2 days), the PLLA / pCN bone scaffold caused apoptosis of some tumor cells.

[0074] In this embodiment, the biocompatibility test found that under dark conditions, the PLLA bone scaffold had no obvious toxicity to cells, showing good biocompatibility.

[0075] The above embodiments and comparative examples are only used to illustrate the technical solutions of the present invention, rather than to limit them. Although the invention has been described in detail with reference to the aforementioned embodiments and comparative examples, a person skilled in the art should understand that the technical solutions described in the aforementioned examples can still be modified, or some of the technical features can be replaced by equivalents. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the various examples of the present invention.

Claims

1. A method for preparing an enhanced graphite phase carbon nitride composite bone scaffold material, the preparation steps are as follows: (1) synthesizing bCN powder by calcination method, and then synthesizing pCN powder by one-step ion exchange method; (2) Growing Ce6 on pCN nanosheets by magnetic stirring to obtain Ce6@pCN composite powder; (3) PLLA powder was mixed with Ce6@pCN composite powder and subjected to dispersion, centrifugation, vacuum drying and other steps to obtain PLLA / Ce6@pCN powder, which was then printed by selective laser sintering technology to prepare PLLA / Ce6@pCN composite bone scaffold.

2. The method for preparing the enhanced graphite phase carbon nitride composite bone scaffold material according to claim 1, characterized in that: The preparation steps of the Ce6@pCN composite powder are as follows: melamine powder is taken through a calcination method to obtain bCN powder; bCN is dispersed in a hydrochloric acid solution and centrifuged to obtain pCN powder; pCN and Ce6 are co-dispersed in deionized water to prepare a Ce6@pCN composite solution; the composite solution is first repeatedly washed and centrifuged with deionized water and ethanol, and then dried in a vacuum drying oven to obtain Ce6@pCN powder.

3. The method for preparing a reinforced graphite phase carbon nitride composite bone scaffold according to claim 1, characterized in that: The PLLA / Ce6@pCN composite powder comprises the following components by weight: 92-98 parts of PLLA powder and 2-8 parts of Ce6@pCN composite powder.

4. The method for preparing a reinforced graphite phase carbon nitride composite bone scaffold according to claim 3, characterized in that: The Ce6@pCN composite powder includes the following components by weight: 8-12 parts of Ce6 powder and 88-92 parts of pCN powder.

5. The method for preparing a reinforced graphite phase carbon nitride composite bone scaffold according to claim 3 or 4, characterized in that: The preparation method of the PLLA / Ce6@pCN composite powder is as follows: taking the composite bone scaffold material components, dispersing them in anhydrous ethanol to obtain a suspension, and then drying and grinding to obtain the PLLA / Ce6@pCN powder.

6. The method for preparing a reinforced graphite phase carbon nitride composite bone scaffold according to claim 2, characterized in that: The bCN and pCN nanosheets have a sheet diameter of 1-5 um and a thickness of 0.5-3 nm.

7. The method for preparing a reinforced graphite phase carbon nitride composite bone scaffold according to claim 1, characterized in that: The dispersion method is ultrasound and / or magnetic stirring, the ultrasonic dispersion time is 10-30 minutes, the temperature is 10-40°C; the magnetic stirring dispersion time is 10-300 minutes, the temperature is 20-30°C; the centrifugal time is 3-10 minutes, and the centrifugal speed is 10000-15000r / min.

8. The method for preparing a reinforced graphite phase carbon nitride composite bone scaffold according to claim 1, characterized in that: The vacuum drying temperature is set to 50-80°C, the drying time is 10-24 hours, and the grinding time of the dried powder is 10-60 minutes.

9. The method for preparing a reinforced graphite phase carbon nitride composite bone scaffold according to claim 1, characterized in that: The prepared PLLA / Ce6@pCN powder was placed in a laser sintering 3D printing system for personalized printing according to 3D modeling; The steps of preparing the composite bone scaffold are: preheating the powder, spreading the powder on the printing interface, scanning in layers to solidify the powder material, spreading the next layer of powder, sintering and molding, and removing excess unsintered powder after repeated steps to obtain the composite bone scaffold.

10. The method for preparing a reinforced graphite phase carbon nitride composite bone scaffold according to claim 9, characterized in that: The process parameters of selective laser sintering are: laser power is 0.5-2W, scanning speed is 100-200m / s, layer thickness is 0.1-0.2mm, and powder bed preheating temperature is 140-160℃.